Li S.Han Z.He J.Gao S.Liu D.Liu L.He J.Huang Y.Xu S.Mao W.Tan Q.Chen C.Li X.Zhang Z.Jiang G.Xu L.Zhang L.Fu J.Li H.Wang Q.Tan L.Li D.Zhou Q.Fu X.Jiang Z.Chen H.Fang W.Zhang X.Li Y.Tong T.Yu Z.Liu Y.Zhi X.Yan T.Zhang X.Imperatori A.Ibrahim M.Novoa N.M.Ng C.S.H.Petersen R.H.JIN-SHING CHENFukuchi Y.Brunelli A.Ismail M.Valverde J.A.Rodriguez-Lucas C.2020-03-302020-03-3020182072-1439https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057591695&doi=10.21037%2fjtd.2018.10.108&partnerID=40&md5=c4f982a3479b7a428c4eb28dcc7d7a61https://scholars.lib.ntu.edu.tw/handle/123456789/480990[SDGs]SDG3aminoglycoside; antibiotic agent; antifungal agent; beta lactam antibiotic; carbapenem derivative; ceftaroline; cephalosporin derivative; colistin; fosfomycin; linezolid; macrolide; quinoline derived antiinfective agent; teicoplanin; tigecycline; antibiotic resistance; antibiotic therapy; Article; bacterial infection; bacterium identification; body fluid; combination drug therapy; consensus; contamination; drug administration; drug contraindication; drug indication; human; infection prevention; intraoperative period; kidney failure; liver disease; lung surgery; medical expert; medical society; multidrug resistance; mycosis; nonhuman; postoperative complication; postoperative infection; surgical technique; thorax surgery; translational research; treatment durationjournal article10.21037/jtd.2018.10.1082-s2.0-85057591695